Matches in SemOpenAlex for { <https://semopenalex.org/work/W2384810760> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W2384810760 abstract "BACKGROUND: Recombinant bone morphogenetic protein-2 can promote tissue engineering bone vascularization, but its biological rules targeting human cells are not clear. At present, there is in which report on recombinant bone morphogenetic protein-2 adjusts the expression of vascular endothelial growth factor in human cells. OBJECTIVE: To observe and compare the expression of vascular endothelial growth factor in human adipose-derived mesenchymal stem cells on gene level and protein level at different time points after induced with human recombinant bone morphogenetic protein-2. METHODS: Adipose-derived mesenchymal stem cells were separated from adult human adipose tissues and cultured until passage 3, then divided into induced group and control group. The cells in the induced group were induced by human recombinant bone morphogenetic protein-2 which final concentration was 100 μg/L, then the samples were collected at 3, 6, 12, 18, 24, 36 and 48 hours after induction. Reverse transcription-PCR and enzyme-linked immunosorbent assay were used to detect vascular endothelial growth factor expression on gene level and protein level, compared with the control group. RESULTS AND CONCLUSION: Human recombinant bone morphogenetic protein-2 adjusted vascular endothelial growth factor expression of adipose mesenchymal stem cells in a time-dependent manner, and the expression of vascular endothelial growth factor changed at different time points. Compared with the control group, human recombinant bone morphogenetic protein-2 could suppress vascular endothelial growth factor expression at 3-6 hours (P 0.05), while at 18-24 hours, human recombinant bone morphogenetic protein-2 could promote vascular endothelial growth factor expression (P 0.05). These two time periods should be paid attention when using human recombinant bone morphogenetic protein-2 to promote tissue engineering bone vascularization." @default.
- W2384810760 created "2016-06-24" @default.
- W2384810760 creator A5056907891 @default.
- W2384810760 date "2013-01-01" @default.
- W2384810760 modified "2023-09-24" @default.
- W2384810760 title "Recombinant human bone morphogenetic protein-2 adjusts expression of vascular endothelial growth factor in human adipose-derived mesenchymal stem cells" @default.
- W2384810760 hasPublicationYear "2013" @default.
- W2384810760 type Work @default.
- W2384810760 sameAs 2384810760 @default.
- W2384810760 citedByCount "0" @default.
- W2384810760 crossrefType "journal-article" @default.
- W2384810760 hasAuthorship W2384810760A5056907891 @default.
- W2384810760 hasConcept C104317684 @default.
- W2384810760 hasConcept C125349252 @default.
- W2384810760 hasConcept C126322002 @default.
- W2384810760 hasConcept C134018914 @default.
- W2384810760 hasConcept C167734588 @default.
- W2384810760 hasConcept C171089720 @default.
- W2384810760 hasConcept C181628713 @default.
- W2384810760 hasConcept C198826908 @default.
- W2384810760 hasConcept C202450454 @default.
- W2384810760 hasConcept C202751555 @default.
- W2384810760 hasConcept C2777025900 @default.
- W2384810760 hasConcept C30352789 @default.
- W2384810760 hasConcept C31507581 @default.
- W2384810760 hasConcept C40767141 @default.
- W2384810760 hasConcept C502942594 @default.
- W2384810760 hasConcept C55493867 @default.
- W2384810760 hasConcept C71924100 @default.
- W2384810760 hasConcept C86803240 @default.
- W2384810760 hasConcept C95444343 @default.
- W2384810760 hasConceptScore W2384810760C104317684 @default.
- W2384810760 hasConceptScore W2384810760C125349252 @default.
- W2384810760 hasConceptScore W2384810760C126322002 @default.
- W2384810760 hasConceptScore W2384810760C134018914 @default.
- W2384810760 hasConceptScore W2384810760C167734588 @default.
- W2384810760 hasConceptScore W2384810760C171089720 @default.
- W2384810760 hasConceptScore W2384810760C181628713 @default.
- W2384810760 hasConceptScore W2384810760C198826908 @default.
- W2384810760 hasConceptScore W2384810760C202450454 @default.
- W2384810760 hasConceptScore W2384810760C202751555 @default.
- W2384810760 hasConceptScore W2384810760C2777025900 @default.
- W2384810760 hasConceptScore W2384810760C30352789 @default.
- W2384810760 hasConceptScore W2384810760C31507581 @default.
- W2384810760 hasConceptScore W2384810760C40767141 @default.
- W2384810760 hasConceptScore W2384810760C502942594 @default.
- W2384810760 hasConceptScore W2384810760C55493867 @default.
- W2384810760 hasConceptScore W2384810760C71924100 @default.
- W2384810760 hasConceptScore W2384810760C86803240 @default.
- W2384810760 hasConceptScore W2384810760C95444343 @default.
- W2384810760 hasLocation W23848107601 @default.
- W2384810760 hasOpenAccess W2384810760 @default.
- W2384810760 hasPrimaryLocation W23848107601 @default.
- W2384810760 hasRelatedWork W1970693047 @default.
- W2384810760 hasRelatedWork W1983457706 @default.
- W2384810760 hasRelatedWork W2000042735 @default.
- W2384810760 hasRelatedWork W2030508471 @default.
- W2384810760 hasRelatedWork W2034565337 @default.
- W2384810760 hasRelatedWork W2089713840 @default.
- W2384810760 hasRelatedWork W2124719068 @default.
- W2384810760 hasRelatedWork W2145923208 @default.
- W2384810760 hasRelatedWork W2152861671 @default.
- W2384810760 hasRelatedWork W2156211918 @default.
- W2384810760 hasRelatedWork W2164395242 @default.
- W2384810760 hasRelatedWork W2182773634 @default.
- W2384810760 hasRelatedWork W2377040862 @default.
- W2384810760 hasRelatedWork W2380957638 @default.
- W2384810760 hasRelatedWork W2386612474 @default.
- W2384810760 hasRelatedWork W2387295683 @default.
- W2384810760 hasRelatedWork W2389014111 @default.
- W2384810760 hasRelatedWork W2401875877 @default.
- W2384810760 hasRelatedWork W2613307905 @default.
- W2384810760 hasRelatedWork W2811521132 @default.
- W2384810760 isParatext "false" @default.
- W2384810760 isRetracted "false" @default.
- W2384810760 magId "2384810760" @default.
- W2384810760 workType "article" @default.